It’s been exciting to connect with and learn from the community at the first Little Legs Big Heart Skeletal Dysplasia Conference this weekend in West Palm Beach, Florida. In addition to hearing from members of the community, we had the opportunity to share updates about our research in #achondroplasia and #hypochondroplasia. Thanks to Kristen DeAndrade and The Little Legs Big Heart Foundation for organizing this event and inviting us to be part of it. We were also proud to see one of our RARE Scholars recipients, Jiayi (Bryan) Yan, at the conference presenting his research on the lived experience of adults with achondroplasia. Thank you, Jiayi, for sharing your insightful work.
BioMarin Pharmaceutical Inc.
生物技术研究
San Rafael，CA 174,530 位关注者
We transform lives through genetic discovery.
关于我们
Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. The company develops and commercializes targeted therapies that address the root cause of the genetic conditions that it seeks to treat, helping to better the lives of those struggling with rare genetic disease. BioMarin discoveries have led to eight first or best-in-class commercial treatments and a pipeline of multiple product candidates applying the same science-driven, patient-forward approach to broader group of genetic disorders. The more innovative solutions developed, the more lives BioMarin can impact. Recruitment Fraud Alert Notice Please be aware of fraud or scams from individuals, organizations and/or internet sites claiming to represent BioMarin in recruitment activities. We have an established recruitment process which is required for all posted positions by BioMarin prior to issuing an offer of employment. This BioMarin process requires formal interviews conducted live with personnel representing BioMarin and never requires payments or fees from job applicants. BioMarin does not conduct interviews via texting tools such as RingCentral. In the event you receive a suspicious email message about recruiting on behalf of BioMarin, unless it’s from a BioMarin authorized recruiting partner, do not provide any personal information or pay any fees. Qualified and interested candidates should apply to current openings directly through this BioMarin website. BioMarin accepts no responsibility for any costs or charges incurred as a result of fraudulent activity. If you have lost money or provided your personal identifying information, please contact your bank and report the matter to the FBI via www.ic3.gov. We would also suggest you notify your local police department and monitor your credit. We appreciate your interest in BioMarin & encourage you to visit https://careers.biomarin.com/career-areas to review job opportunities.
- 网站
-
https://www.BioMarin.com
BioMarin Pharmaceutical Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 1,001-5,000 人
- 总部
- San Rafael，CA
- 类型
- 上市公司
- 创立
- 1997
- 领域
- Transform lives through genetic discovery.
地点
BioMarin Pharmaceutical Inc.员工
动态
-
RARE Scholars award recipient Brian DuVal is pursuing his Master of Public Health at Vanderbilt University in Tennessee. Growing up with #hemophilia A shaped Brian’s educational path and influenced his career goals. He aspires to become a leader in the hemophilia community and use his influence to improve the lives of others living with rare conditions. Learn more about Brian and the 2024-25 RARE Scholars: https://bit.ly/3MX5TMi #BioMarinRAREscholars
-
The London chapter of our Black Employee Resource Group (BERG) recently organized an event for employees featuring David Olusoga, a prominent British-Nigerian historian, author and filmmaker. The event was held in honor of Black History Month, recognized every October in the U.K. Discussing this year’s theme – Reclaiming Narratives – David provided examples of work he and other historians are doing to reframe past misrepresentations of Black communities and individuals and honor their contributions to society. We’re grateful to David for sharing his perspective on this topic, and to our BERG team in London for coordinating a meaningful learning opportunity for employees. Learn more about Black History Month in the U.K.: https://bit.ly/3cEnUfv #BlackHistoryMonth #BlackHistoryMonth2024 #BHM #BHM2024
-
-
“I’m the oldest living Alpha in my family, and nothing’s changed, really, except for a diagnosis. The only hope that I’m going to have is going to be a therapy. I want to be a part of that." Kristin is the Pediatric and Rare Liver Diseases Program Director at the Global Liver Institute and a dedicated advocate for people living with alpha-1 antitrypsin deficiency (AATD). Her family history and personal journey with AATD underscore the critical need for research enabling the development of new treatment options for those living with this genetic condition, which can impact the lungs and/or liver. Learn more about AATD and Kristin’s story as we recognize Alpha-1 Awareness Month this November: https://bit.ly/3MFcURX #alpha1awareness #AATD
-
-
Allyson Chan, a 2024 RARE Scholars award recipient, is a freshman at Occidental College studying sociology and politics. Allyson, who is living with mucopolysaccharidosis IVA, is looking forward to exploring Los Angeles and plans to attend law school after completing her undergraduate degree. Learn more about Allyson and the 2024-25 RARE Scholars: https://bit.ly/3MX5TMi #BioMarinRAREscholars #mucopolysaccharidosis
-
Today we announced third-quarter 2024 results, including 28% year-over-year total revenue growth. Investors can read more in our press release: https://bit.ly/4e4Vnhi
-
-
“The pull here was just too strong to ignore. BioMarin’s R&D is truly leveraging some of the greatest genetic science out there.” Since joining BioMarin at the end of September, Gregory Friberg, Executive Vice President and Chief R&D Officer, has been spending time getting to know the company while focusing on building upon what he thinks has set BioMarin apart: the combination of great people, great science and big hearts. We sat down with Greg to learn more about what first drew him to medicine, his career journey and why he’s so excited about BioMarin’s potential. Learn more: https://bit.ly/3BZJRGx
-
-
We’re proud to announce that our Chief Commercial Officer Cristin Hubbard has been appointed to the Biotechnology Innovation Organization (BIO) Board of Directors. BIO is the world’s largest biotech advocacy association focused on advancing the industry, fostering innovation and expanding access to medicines. In her new role, Cristin will be a member of the organization’s Health Section Governing Board. Congrats, Cristin!
-
-
Rebeca Costa describes herself as having a “Carnival spirit.” Since childhood, she has eagerly looked forward to the annual event held in her native Rio de Janeiro. Now, Rebeca – a lawyer, influencer, consultant, podcast host and advocate – is using her voice to help make Carnival more inclusive and accessible. Read about Rebeca’s journey with achondroplasia and her work in accessibility today as we join people around the world in recognizing International Dwarfism Awareness Day. Learn more: https://bit.ly/3YgK0gl #Inclusion #Accessibility #Carnival #Carnival2025 #DwarfismAwareness
-
-
Will McClintock, a two-time RARE Scholars award recipient, is in his sophomore year at the University of Washington and is living with #PKU. He's interested in computer science and business and says he's grateful the RARE Scholars program has enabled him to focus on school and his career. Learn more about Will and the 2024-25 RARE Scholars: https://bit.ly/3MX5TMi #BioMarinRAREscholars #Phenylketonuria